salvia
prattii
prattii
acknowledg
altern
salvia
miltiorrhiza
extens
util
tradit
tibetan
medicin
previou
chemic
investig
prove
salvia
speci
possess
two
main
class
biolog
activ
substanc
phenylpropanoid
diterpen
diterpen
princip
activ
constitu
salvia
plant
numer
pharmacolog
function
includ
antibacteri
antiinflammatori
anticanc
activ
preliminari
experi
crude
diterpenesrich
sampl
prattii
display
consider
antibacteri
activ
staphylococcu
aureu
mic
pseudomona
aeruginosa
mic
acinetobact
baumannii
mic
identifi
main
antibacteri
constitu
sampl
desir
obtain
diterpen
adequ
puriti
quantiti
thu
object
work
develop
effici
process
purif
diterpen
diterpenesrich
sampl
prattii
date
separ
diterpen
salvia
plant
depend
gel
silica
gel
open
column
chromatographi
howev
method
numer
drawback
low
yield
timeconsum
produc
larg
quantiti
solvent
wast
nonsuit
largescal
industri
product
recent
time
highspe
countercurr
chromatographi
liquidliquid
chromatograph
method
propos
isol
diterpen
salvia
plant
even
though
techniqu
offer
highsepar
effici
requir
sever
hour
rather
minut
need
prepar
highperform
liquid
chromatographi
prephplc
prephplc
consid
effici
techniqu
separ
purif
phenol
coumarin
flavonoid
glycosid
intric
mixtur
like
tradit
tibetan
medicin
prefer
chromatographi
method
owe
higher
effici
greater
resolut
better
reproduc
onlin
monitor
automat
control
consequ
prephplc
draw
everincreas
attent
phytochemist
pharma
industri
howev
crude
extract
directli
subject
prephplc
separ
separ
techniqu
usual
requir
enrich
main
compound
crude
extract
hydrophil
interact
liquid
chromatographi
solidphas
extract
hilicsp
employ
stationari
phase
polar
function
group
bond
silica
gel
surfac
extens
use
enrich
compound
interest
natur
product
due
applic
eas
use
regener
well
complementari
select
reversedphas
liquid
chromatographi
studi
report
separ
diterpen
miltiorrhiza
use
highspe
countercurr
chromatographi
report
mention
separ
diterpen
combin
hilicsp
prephplc
henc
studi
aim
develop
valuabl
protocol
purif
four
antibacteri
diterpen
diterpenesrich
prattii
crude
sampl
develop
protocol
succeed
achiev
largescal
prepar
four
highli
pure
diterpen
crude
sampl
prattii
pave
way
potenti
develop
antibacteri
drug
prephplc
experi
perform
hanbon
prephplc
system
hanbon
scienc
technolog
co
ltd
huai
china
system
consist
megress
dynam
axial
compress
column
two
prephplc
pump
sampl
loop
ml
dma
dynam
mixer
uvvi
detector
easychrom
workstat
hplc
analysi
carri
agil
instrument
agil
technolog
co
ltd
santa
clara
ca
usa
consist
pump
uvvi
detector
thermostat
autosampl
agil
workstat
esim
spectra
record
api
mass
spectromet
ab
sciex
milwauke
wi
usa
nmr
spectra
record
bruker
avanc
mhz
bruker
karlsruh
germani
spectromet
use
tetramethylsilan
tm
intern
standard
analyt
grade
ethanol
nhexan
ethanol
methanol
util
sampl
extract
well
hilicsp
prephplc
order
tianjin
chemic
factori
tianjin
china
chromatograph
grade
nhexan
ethanol
methanol
acetonitril
employ
hplc
analysi
bought
concord
chemic
ltd
tianjin
china
water
purifi
laboratori
ultrapur
water
system
chengdu
ultra
tech
chengdu
china
xion
megress
stationari
phase
purchas
acchrom
technolog
co
ltd
beij
china
hanbon
scienc
technolog
co
ltd
huai
china
respect
xion
mm
mm
megress
mm
mm
analyt
column
obtain
acchrom
beij
china
hanbon
scienc
technolog
co
ltd
huai
china
respect
silica
gel
mm
mm
xaqua
mm
mm
analyt
column
obtain
acchrom
beij
china
root
prattii
obtain
yushu
qinghai
provinc
china
septemb
authent
prof
lijuan
mei
northwest
institut
plateau
biolog
chines
academi
scienc
sampl
hand
qinghaitibetan
plateau
museum
biolog
qpmb
dri
mill
sampl
kg
extract
thrice
day
use
ethanol
l
extract
room
temperatur
extract
combin
l
concentr
use
rotari
evapor
partial
dri
concentr
approxim
l
suspend
distil
water
l
suspens
subsequ
load
onto
preprocess
middl
chromatogram
isol
gel
mci
column
cm
cm
kg
wash
ethanol
l
elut
ethanol
l
dri
yield
g
crude
diterpenesrich
sampl
ensu
hilicsp
presepar
crude
diterpenesrich
sampl
dissolv
methanol
mix
polyamid
dri
use
rotari
evapor
afterward
solid
mixtur
load
onto
xion
solidphas
extract
mediumpressur
column
mm
mm
contain
g
solidphas
xion
elut
four
column
volum
nhexaneethanol
vv
success
eluent
hilicsp
column
collect
ml
fraction
analyz
hplc
use
xion
mm
mm
analyt
column
eluent
composit
collect
combin
accord
hplc
analysi
final
fraction
elut
nhexaneethanol
vv
gave
fraction
g
fraction
ii
g
fraction
iii
g
respect
three
fraction
store
refriger
subsequ
prepar
separ
staphylococcu
aureu
atcc
pseudomona
aeruginosa
atcc
acinetobact
baumannii
obtain
peopl
liber
armi
pla
gener
hospit
use
instruct
strain
antibacteri
activ
assay
muellerhinton
broth
use
cultur
bacteria
increas
optic
densiti
nm
use
monitor
growth
twofold
serial
dilut
activ
extract
diterpen
dissolv
dimethyl
sulfoxid
dmso
ad
sensit
strain
respect
minimum
inhibitori
concentr
mic
defin
lowest
concentr
activ
extract
diterpen
need
inhibit
growth
sensit
strain
observ
follow
incub
h
accord
clinic
laboratori
standard
institut
clsi
wayn
pa
usa
midexponenti
broth
sensit
strain
treat
without
extract
diterpen
dmso
consid
neg
control
growth
dmsotreat
sensit
strain
monitor
elimin
effect
dmso
midexponenti
broth
sensit
strain
treat
antibiot
cefotaxim
vancomycin
mgml
use
posit
control
purif
diterpen
perform
hanbon
prephplc
system
fraction
ii
iii
dissolv
methanol
inject
onto
dynam
axial
compress
column
contain
megress
stationari
phase
flow
rate
mlmin
inject
volum
ml
mobil
phase
consist
vv
formic
acid
water
vv
formic
acid
methanol
differ
ratio
fraction
fraction
ii
iii
effluent
analyz
use
uvvi
detector
nm
manual
obtain
base
chromatogram
collect
fraction
subsequ
evapor
dryness
reduc
pressur
hplc
analysi
separ
diterpen
carri
xaqua
flow
rate
mlmin
chromatogram
record
nm
water
methanol
mobil
phase
b
respect
gradient
elut
step
follow
min
b
chemic
structur
separ
diterpen
establish
uv
mass
spectrometri
uv
spectra
record
use
dad
detector
agil
system
esim
spectra
record
api
mass
spectromet
posit
ion
mode
wherea
nmr
spectra
record
bruker
avanc
iii
mhz
spectromet
simplifi
develop
reversedphas
prephplc
method
improv
lifespan
reversedphas
stationari
phase
crude
diterpenesrich
extract
complex
composit
usual
requir
pretreat
select
appropri
pretreat
two
chromatograph
stationari
phase
ie
bare
silica
gel
xion
stationari
phase
three
separ
mode
test
separ
crude
extract
repres
separ
chromatogram
shown
figur
observ
figur
b
main
diterpen
inferior
resolut
bare
silica
gel
stationari
phase
compar
xion
stationari
phase
elut
condit
nhexaneethanol
solvent
system
main
diterpen
show
weak
retent
xion
stationari
phase
mobil
phase
vv
formic
acid
acetonitril
water
figur
accord
manufactur
xion
cysteinebond
silica
gel
stationari
phase
cystein
polar
group
give
xion
stationari
phase
retent
behavior
normalphas
chromatographi
hydrophil
interact
chromatographi
thu
xion
stationari
phase
employ
sampl
pretreat
normalphas
mode
due
favor
separ
profil
figur
analyt
column
mm
mm
hydrophil
interact
chromatographi
usual
pack
g
stationari
phase
approxim
condit
high
pressur
one
column
volum
ml
one
column
volum
weight
stationari
phase
g
calcul
use
follow
equat
stationari
phase
pack
densiti
analyt
column
hilicsp
column
condit
high
pressur
respect
ra
rp
diamet
analyt
column
mm
hilicsp
column
mm
respect
ha
hp
column
length
analyt
column
mm
hilicsp
column
actual
pack
length
mm
respect
similarli
mp
stationari
phase
weight
analyt
column
hilicsp
column
respect
stationari
phase
pack
densiti
analyt
column
hilicsp
column
uniform
condit
high
pressur
thu
equat
could
simplifi
calcul
show
hilicsp
column
mm
mm
pack
g
stationari
phase
one
column
volum
ml
therefor
sampl
load
onto
xion
solidphas
extract
column
elut
ml
four
column
volum
nhexaneethanol
vv
success
gradient
elut
use
xion
analyt
column
hilicsp
column
hplc
analysi
result
reveal
diterpen
fraction
mainli
present
eluat
vv
nhexaneethanol
figur
show
target
fraction
figur
ii
figur
iii
figur
compar
figur
figur
could
seen
diterpen
divid
three
group
fraction
ii
iii
nhexaneethanol
mobil
phase
xion
stationari
phase
follow
hilicsp
column
chromatographi
g
fraction
g
fraction
ii
g
fraction
iii
obtain
g
antibacteri
crude
diterpenesrich
sampl
antibacteri
activ
mic
test
fraction
shown
tabl
fraction
display
higher
antimicrobi
activ
compar
crude
diterpenesrich
sampl
staphylococcu
aureu
pseudomona
aeruginosa
acinetobact
baumannii
therefor
interest
identifi
antibacteri
compound
bioactiv
fraction
ii
iii
separ
attain
good
separ
profil
stationari
phase
use
analyt
hplc
prepar
liquid
chromatographi
elut
condit
fraction
ii
iii
standard
megress
analyt
column
wherea
linear
magnifi
methodolog
util
transform
analyt
flow
rate
prepar
level
use
follow
equat
ra
rp
diamet
analyt
column
mm
prepar
column
mm
respect
similarli
fa
fp
flow
rate
analyt
column
prepar
column
respect
conveni
isocrat
elut
condit
sampl
solut
optim
megress
analyt
column
mm
mm
flow
rate
mlmin
fa
compar
flow
rate
megress
prepar
column
mm
mm
determin
mlmin
fp
henc
mlmin
use
conveni
load
amount
similar
linear
magnifi
technolog
employ
equat
concentr
mgml
fraction
ii
mgml
fraction
iii
sampl
solut
analyt
prepar
column
equat
could
simplifi
mp
load
amount
analyt
prepar
column
respect
similarli
va
vp
inject
volum
analyt
prepar
column
respect
inject
volum
load
amount
analyt
column
prepar
column
va
ml
respect
howev
volum
low
meet
requir
highli
profici
prepar
prepar
inject
volum
larger
smaller
sampl
loop
ml
fraction
ii
iii
actual
oper
optim
condit
separ
chromatogram
fraction
analyt
level
prepar
level
shown
figur
optim
analyt
figur
prepar
figur
chromatograph
profil
similar
except
slight
increas
retent
time
peak
prepchromatogram
peak
figur
e
resolut
analyt
prepar
chromatogram
rsa
rsp
respect
due
sampleoverload
prepar
column
diffus
effect
target
compound
chromatograph
peak
collect
base
uv
absorpt
intens
consider
enhanc
puriti
overal
mg
fraction
ii
well
mg
fraction
iii
separ
obtain
mg
peak
fraction
mg
peak
fraction
mg
peak
fraction
mg
peak
fraction
recoveri
respect
puriti
four
isol
diterpen
determin
hplc
xaqua
analyt
column
mm
mm
result
given
figur
figur
show
compound
possess
puriti
greater
compound
compound
compound
compound
uv
spectra
four
diterpen
includ
inset
figur
figur
accord
previou
public
addit
antibacteri
activ
four
isol
diterpen
also
test
tabl
compound
show
strongest
activ
mic
staphylococcu
aureu
pseudomona
aeruginosa
acinetobact
baumannii
wherea
compound
also
display
potent
activ
speci
mic
chemic
structur
isol
diterpen
determin
esim
spectroscopi
compar
spectra
compound
literatur
data
conclud
compound
repres
tanshinon
iia
salvinolon
cryptotanshinon
ferruginol
chemic
structur
tanshinon
iia
compound
salvinolon
cryptotanshinon
ferruginol
shown
figur
detail
data
compound
given
compound
red
powder
esim
mz
h
mhz
j
hz
j
hz
j
hz
mhz
esim
data
compound
agre
literatur
data
report
tanshinon
iia
compound
red
powder
esim
mz
h
mhz
j
hz
j
hz
mhz
esim
data
compound
agre
literatur
data
report
salvinolon
compound
orang
powder
esim
mz
h
mhz
j
hz
j
hz
j
hz
dd
j
hz
j
hz
j
hz
mhz
esim
data
compound
agre
literatur
data
report
cryptotanshinon
compound
yellow
powder
esim
mz
h
mhz
dd
j
hz
j
hz
j
hz
mhz
esim
data
compound
agre
literatur
data
report
ferruginol
effici
prepar
procedur
involv
nonaqu
hilicsp
follow
prephplc
develop
prepar
antibacteri
tanshinon
iia
salvinolon
cryptotanshinon
ferruginol
crude
diterpenesrich
sampl
root
prattii
initi
hilicsp
use
separ
g
crude
diterpenesrich
sampl
three
fraction
g
fraction
g
fraction
ii
g
fraction
iii
prephplc
column
contain
megress
stationari
phase
use
isol
diterpen
three
fraction
separ
fraction
megress
perform
optim
separ
condit
megress
analyt
column
transform
condit
megress
prepar
column
coelut
diterpen
hilicsp
stationari
phase
separ
largescal
sampl
amount
megress
revers
stationari
phase
brought
divers
sampl
separ
mechan
stationari
phase
owe
differ
select
optim
collect
mode
mg
tanshinon
iia
mg
salvinolon
mg
cryptotanshinon
mg
ferruginol
greater
puriti
prepar
mg
fraction
ii
well
mg
fraction
iii
singl
prepar
purifi
diterpen
identifi
tanshinon
iia
salvinolon
cryptotanshinon
ferruginol
uv
mass
nmr
spectroscopi
therefor
present
work
offer
excel
protocol
prepar
activ
diterpen
plant
sourc
